Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy
Clinical trial NCT02495181 · COMPLETED
Trial details
- NCT number
- NCT02495181
- Sponsor
- Association for Innovation and Biomedical Research on Light and Image
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-23
- Primary completion
- 2017-08-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.